Emefcy Group Limited Announces First China Demonstration Plant In Operation And Commissioned Ahead Of Schedule

This Plant in Wuxi Municipal Design Institute, Provides a Key Reference Site For Chinese Customers

Melbourne, Australia and Caesarea, Israel: Emefcy Group Limited (“Emefcy”) is pleased to announce that less than two weeks since arriving on site, its first demonstration packaged plant is in operation and has been commissioned ahead of schedule at, one of the top institutes in China and an ideal, state-of-the-art location for Chinese customers to visit. Wuxi Municipal Design Institute is a subsidiary of the Wuxi Guolian Environmental & Energy Group Co. Ltd. (“Wuxi Guolian”), a leading state-owned enterprise and provider of environmental protection services throughout Jiangsu, mainland China, and international markets. Wuxi was the first of several Chinese sales distribution partnerships announced by Emefcy Group.

The demo plant has a treatment capacity of 24,000 liters per day and is continuously treating wastewater to the very high standard for which it was designed. Plant data is now being collected to support Wuxi obtaining provincial certification for Emefcy’s MABR product throughout Jiangsu Province in the months ahead. According to the Chinese Government’s Five-Year Plan (the “Plan”) announced earlier this year, new rural wastewater treatment plants supporting an estimated population of some twenty-two million people in Jiangsu Province are expected to be built over the next five years. The total revenue potential for Emefcy’s MABR product accessible in Jiangsu is estimated at approximately A$1B in this Province alone. Importantly, Wuxi Guolian has its own financial arm to support the financing of plant deployments.

“Thanks to the excellent cooperation between Emefcy and our partner Wuxi Municipal Design Institute, we are very pleased to have installed and commissioned this demo plant in less than two weeks, achieving a key milestone of our China plan ahead of schedule,” said Richard Irving, Executive Chairman of Emefcy. “We look forward to obtaining provincial certification for our MABR as well as welcoming many potential Chinese customers to this demo site over the coming weeks.”

“Due to its substantial energy savings and resulting significantly lower operating costs, the interest in our MABR product is being widespread within the China market, as evidenced by our already signing four Chinese partners,” said Ilan Wilf, Vice President of Sales, Emefcy. “We anticipate that welcoming potential customers to this site and sharing its excellent performance data will accelerate adoption of our MABR product for rural wastewater treatment throughout China.”

About Emefcy Group Limited
Emefcy develops, manufactures and markets new, energy-efficient MABR based wastewater treatment solutions, aiming to change the economics of various markets and addressing the growing global demand for clean water in municipal and industrial plants.

Customer contracts have already been signed in Israel, US Virgin Islands, Ethiopia, and China, and plants in Israel, the US Virgin Islands and now China have been successfully commissioned. Additional MABR based wastewater solutions from Emefcy’s extensive R&D operations are scheduled to be announced in the coming year.

Emefcy’s advanced manufacturing facility in Israel is equipped with state of the art production machinery, enabling the Company to control the quality and meet the current quantity requirements of its markets. With several global innovation awards and a strong scientific background, Emefcy is at the forefront of the next generation of MABR based wastewater treatment. For more information, visit www.emefcy.com.